Table 5.
Probability of COVID-19 progression according to the final logistic model.
| IL-10 ≤ 26 and IL12p70 ≤ 0.91 | IL10 ≤ 26 and IL12p70 > 0.91 | IL10 > 26 and IL12p70 ≤ 0.91 | IL10 > 26 and IL12p70 > 0.91 | |
|---|---|---|---|---|
| No clinical risk factors † | <0.1% | <0.1% | <0.1% | 0.3% |
| Only diabetes | <0.1% | 0.1% | 0.2% | 8.9% |
| Only obesity | <0.1% | 0.2% | 0.3% | 10.9% |
| Only significant lung involvement ‡ | <0.1% | <0.1% | <0.1% | 2.3% |
| Diabetes + obesity | 0.1% | 5.3% | 8.3% | 81.5% |
| Diabetes + significant lung involvement | < 0.1% | 1.1% | 1.7% | 45.9% |
| Obesity + significant lung involvement | < 0.1% | 1.3% | 2.1% | 51.6% |
| Diabetes + obesity + significant lung involvement | 1.0% | 32.8% | 43.9% | 97.5% |
IL, interleukin. Biomarker values are presented in pg/mL.
†
Clinical risk factors in the model are diabetes, obesity, and significant lung involvement on admission.
‡
Oxygen saturation ≤ 93% or >50% lung involvement on computed tomography examination.